Physician profile
Hesham A Elsharkawy
NPI 1699949446
$188,887.36
in general payments reported to CMS, 2019-2025
13 companies · $62K in 2025
The $62K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $776 · 2021: $941 · 2022: $5,746 · 2023: $35K · 2024: $51K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $122K · Travel and Lodging: $21K · Food and Beverage: $4,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,248.96 |
| Travel and Lodging | $20,723.38 |
| Food and Beverage | $4,661.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $86,703.12 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $65,245.97 | 2019-2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $32,085.92 | 2019-2020 | |
| Boston Scientific Corporation | $1,961.34 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,862.47 | 2019-2022 | |
| Abbott Laboratories | $259.68 | 2024-2025 | Eterna, Proclaim |
| Medtronic, INC. | $226.63 | 2021-2022 | |
| Si-Bone, INC. | $177.13 | 2024 | |
| Mml US, INC. | $166.38 | 2024 | Reactiv8 |
| Heron Therapeutics, INC. | $80.52 | 2022 | |
| Medtronic USA, INC. | $76.09 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.63 | 2019-2020 | |
| Relievant Medsystems, INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hesham Elsharkawy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.